Weber, innovación en evaluación económica, eficacia y sostenibilidad

Ofrecemos consultoría especializada que genera valor mediante soluciones innovadoras y tecnológicas en áreas regulatorias, farmacoeconómicas, economía de la salud, acceso al mercado y marketing.

Weber potencia más de 20 años de experiencia consolidada en el mercado

Conoce el nuevo Weber

Últimas noticias:

Fundación Weber and EUPATI-ESPAÑA sign a collaboration framework agreement in order to support access to therapeutic innovation and contribute to improving the well-being of all citizens https://www.weber.org.es/wp-content/uploads/2023/02/EUPATI-1.jpg 1299 814 Weber Weber https://www.weber.org.es/wp-content/uploads/2023/02/EUPATI-1.jpg febrero 20, 2023 febrero 20, 2023

febrero 20, 2023
No hay comentarios

Fundación Weber and EUPATI-ESPAÑA sign a collaboration framework agreement in order to support access to therapeutic innovation and contribute to improving the well-being of all citizens

This agreement will promote and monitor the impact of citizen participation throughout the development cycle of innovative therapies Based on a close and continuous collaboration between researchers and patient associations, it will be possible to propose real solutions to real needs. Matching with the World Day of Social Justice, this joint project between two organizations…

Europe Rare Disease Summit 2023 https://www.weber.org.es/wp-content/uploads/2023/02/CARATULA-NOTICIAS-Bamberg-In.jpg 768 312 Weber Weber https://www.weber.org.es/wp-content/uploads/2023/02/CARATULA-NOTICIAS-Bamberg-In.jpg febrero 3, 2023 febrero 3, 2023

febrero 3, 2023
No hay comentarios

Europe Rare Disease Summit 2023

Bamberg Health, in collaboration with key industry players, including Weber, is organizing the Europe Rare Disease Summit 2023 at the Hotel Ilunion Pio XII on Wednesday, February 15. It will bring together local and European government authorities, members of the European Commission and the European Parliament, large public and private hospital groups, research centers, pharmaceutical…

Weber joins Vivactis Group to reinforce its Market Access capabilities https://www.weber.org.es/wp-content/uploads/2023/02/Nota-de-prensa-Vivactis-Weber-1.jpg 562 265 Weber Weber https://www.weber.org.es/wp-content/uploads/2023/02/Nota-de-prensa-Vivactis-Weber-1.jpg febrero 2, 2023 febrero 2, 2023

febrero 2, 2023
No hay comentarios

Weber joins Vivactis Group to reinforce its Market Access capabilities

Brussels, the 2nd of February – Vivactis Group, the leading European healthcare consultancy group, announces its acquisition of Weber, a Market Access Consultancy firm and specialist in Health Economics and Outcomes Research (HEOR). The acquisition strengthens the Vivactis HM3A Market Access branch by expanding the reach in Market Access throughout Europe, as well as adding…